These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 8785394

  • 41. Antibodies to Staphylococcus aureus serotype 8 capsular polysaccharide react with and protect against serotype 5 and 8 isolates.
    Park S, Gerber S, Lee JC.
    Infect Immun; 2014 Dec; 82(12):5049-55. PubMed ID: 25245803
    [Abstract] [Full Text] [Related]

  • 42. Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial.
    MacDonald NE, Halperin SA, Law BJ, Forrest B, Danzig LE, Granoff DM.
    JAMA; 1998 Nov 18; 280(19):1685-9. PubMed ID: 9832000
    [Abstract] [Full Text] [Related]

  • 43. O-Acetylation is essential for functional antibody generation against Staphylococcus aureus capsular polysaccharide.
    Scully IL, Pavliak V, Timofeyeva Y, Liu Y, Singer C, Anderson AS.
    Hum Vaccin Immunother; 2018 Jan 02; 14(1):81-84. PubMed ID: 29182428
    [Abstract] [Full Text] [Related]

  • 44. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine.
    Kasper DL, Paoletti LC, Wessels MR, Guttormsen HK, Carey VJ, Jennings HJ, Baker CJ.
    J Clin Invest; 1996 Nov 15; 98(10):2308-14. PubMed ID: 8941648
    [Abstract] [Full Text] [Related]

  • 45. SA4Ag, a 4-antigen Staphylococcus aureus vaccine, rapidly induces high levels of bacteria-killing antibodies.
    Begier E, Seiden DJ, Patton M, Zito E, Severs J, Cooper D, Eiden J, Gruber WC, Jansen KU, Anderson AS, Gurtman A.
    Vaccine; 2017 Feb 22; 35(8):1132-1139. PubMed ID: 28143674
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Clearance of Pseudomonas aeruginosa from normal rat lungs after immunization with somatic antigens or toxin A.
    Johansen HK, Cryz SJ, Høiby N.
    APMIS; 1994 Jul 22; 102(7):545-53. PubMed ID: 7917224
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Synthesis and characterization of Escherichia coli O18 O-polysaccharide conjugate vaccines.
    Cryz SJ, Cross AS, Sadoff JC, Fürer E.
    Infect Immun; 1990 Feb 22; 58(2):373-7. PubMed ID: 2105272
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Safety and immunogenicity of Escherichia coli O18 O-specific polysaccharide (O-PS)-toxin A and O-PS-cholera toxin conjugate vaccines in humans.
    Cryz SJ, Cross AS, Sadoff JC, Wegmann A, Que JU, Fürer E.
    J Infect Dis; 1991 May 22; 163(5):1040-5. PubMed ID: 1708398
    [Abstract] [Full Text] [Related]

  • 52. Clinical Studies of Escherichia coli O157:H7 Conjugate Vaccines in Adults and Young Children.
    Szu SC, Ahmed A.
    Microbiol Spectr; 2014 Dec 22; 2(6):. PubMed ID: 26104443
    [Abstract] [Full Text] [Related]

  • 53. Evaluation of monophosphoryl lipid A (MPL) as an adjuvant. Enhancement of the serum antibody response in mice to polysaccharide-protein conjugates by concurrent injection with MPL.
    Schneerson R, Fattom A, Szu SC, Bryla D, Ulrich JT, Rudbach JA, Schiffman G, Robbins JB.
    J Immunol; 1991 Oct 01; 147(7):2136-40. PubMed ID: 1918948
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Safety and immunogenicity of PRP-T combined with DTP: excretion of capsular polysaccharide and antibody response in the immediate post-vaccination period.
    Miller MA, Meschievitz CK, Ballanco GA, Daum RS.
    Pediatrics; 1995 Apr 01; 95(4):522-7. PubMed ID: 7700752
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Depression of anticapsular antibody after immunization with Haemophilus influenzae type b polysaccharide-diphtheria conjugate vaccine.
    Marchant CD, Band E, Froeschle JE, McVerry PH.
    Pediatr Infect Dis J; 1989 Aug 01; 8(8):508-11. PubMed ID: 2788860
    [Abstract] [Full Text] [Related]

  • 60. Murine immune responses to Neisseria meningitidis group C capsular polysaccharide and a thymus-dependent toxoid conjugate vaccine.
    Rubinstein LJ, García-Ojeda PA, Michon F, Jennings HJ, Stein KE.
    Infect Immun; 1998 Nov 01; 66(11):5450-6. PubMed ID: 9784556
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.